Question 59

Celexa and Paxil represent a therapeutic duplication.

Celexa and Paxil are both selective serotonin reuptake inhibitors (SSRIs) used for the treatment of depression and anxiety, indicating that their use together constitutes therapeutic duplication.

A) Celexa and Paxil

This option is correct as both medications belong to the same class of SSRIs and are prescribed for similar mental health conditions. The concurrent use of these drugs can increase the risk of side effects without providing additional therapeutic benefit, thus qualifying as a therapeutic duplication.

B) Celexa and Toprol XL

This option is incorrect because Celexa is an SSRI used for mental health conditions, while Toprol XL is a beta-blocker used for hypertension and heart-related issues. These medications serve different therapeutic purposes and do not overlap in their indications.

C) Ditropan XL and Paxil

This option is also incorrect. Ditropan XL is an anticholinergic medication used primarily for overactive bladder, whereas Paxil is an SSRI for depression and anxiety. There is no therapeutic duplication since they target entirely different health issues.

D) Ditropan XL and Toprol XL

This option is incorrect as well. Ditropan XL and Toprol XL serve different therapeutic roles, with Ditropan focusing on urinary conditions and Toprol XL addressing cardiovascular issues. Thus, there is no overlap or duplication in their therapeutic uses.

Conclusion

The identification of Celexa and Paxil as a therapeutic duplication is based on their shared classification as SSRIs aimed at treating similar conditions. In contrast, the other options fail to demonstrate therapeutic duplication due to their distinct pharmacological categories and therapeutic goals. Understanding these distinctions is crucial for ensuring safe and effective medication management.